TEVA PHARMACEUTICAL INDS LTD's ticker is and the CUSIP is 881624959. A total of 7 filers reported holding TEVA PHARMACEUTICAL INDS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,303,780 | +145.2% | 323,900 | +81.1% | 0.00% | +200.0% |
| Q2 2023 | $1,347,117 | -68.3% | 178,900 | -62.7% | 0.00% | -80.0% |
| Q1 2023 | $4,249,770 | +40.9% | 480,200 | +45.2% | 0.01% | 0.0% |
| Q4 2022 | $3,015,984 | -1.0% | 330,700 | -12.4% | 0.01% | +25.0% |
| Q3 2022 | $3,046,000 | -24.7% | 377,400 | -29.8% | 0.00% | -33.3% |
| Q2 2022 | $4,045,000 | -2.0% | 537,900 | +22.4% | 0.01% | +50.0% |
| Q1 2022 | $4,127,000 | -5.2% | 439,500 | -19.1% | 0.00% | 0.0% |
| Q4 2021 | $4,353,000 | +23.4% | 543,500 | +52.5% | 0.00% | 0.0% |
| Q2 2021 | $3,528,000 | +1.2% | 356,400 | +18.0% | 0.00% | -20.0% |
| Q1 2021 | $3,485,000 | +40.9% | 302,000 | +17.8% | 0.01% | +66.7% |
| Q4 2020 | $2,473,000 | +62.8% | 256,300 | +52.0% | 0.00% | +50.0% |
| Q3 2020 | $1,519,000 | -35.6% | 168,600 | -11.8% | 0.00% | -60.0% |
| Q2 2020 | $2,357,000 | -21.5% | 191,200 | -42.8% | 0.01% | -16.7% |
| Q1 2020 | $3,002,000 | +39.4% | 334,300 | +52.2% | 0.01% | 0.0% |
| Q4 2019 | $2,153,000 | +14.2% | 219,700 | -19.8% | 0.01% | 0.0% |
| Q3 2019 | $1,885,000 | -10.8% | 274,000 | +19.7% | 0.01% | -14.3% |
| Q2 2019 | $2,113,000 | +28.9% | 228,900 | +119.0% | 0.01% | +16.7% |
| Q1 2019 | $1,639,000 | -4.7% | 104,500 | -6.3% | 0.01% | +20.0% |
| Q4 2018 | $1,719,000 | – | 111,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Markets Trading UK LLP | 2,245,200 | $21,082,000 | 0.30% |
| GROUP ONE TRADING, L.P. | 4,396,500 | $41,283,000 | 0.04% |
| SIMPLEX TRADING, LLC | 1,490,700 | $13,997,000 | 0.01% |
| IMC-Chicago, LLC | 439,500 | $4,127,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |